Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Liabilities and Shareholders Equity (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $508.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 4.86% to $508.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 billion, a 23.22% increase, with the full-year FY2025 number at $508.1 million, down 4.86% from a year prior.
  • Liabilities and Shareholders Equity was $508.1 million for Q4 2025 at PROCEPT BioRobotics, down from $511.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $534.0 million in Q4 2024 to a low of $272.4 million in Q2 2023.
  • A 5-year average of $391.9 million and a median of $374.2 million in 2024 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 167.54% in 2021, then dropped 12.38% in 2023.
  • PROCEPT BioRobotics' Liabilities and Shareholders Equity stood at $337.0 million in 2021, then dropped by 8.22% to $309.3 million in 2022, then skyrocketed by 30.84% to $404.7 million in 2023, then skyrocketed by 31.95% to $534.0 million in 2024, then dropped by 4.86% to $508.1 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Liabilities and Shareholders Equity are $508.1 million (Q4 2025), $511.5 million (Q3 2025), and $513.1 million (Q2 2025).